Nektar Therapeutics
Closed
76 0.88
Overview
Share price change
24h
Min
75.34
Max
76.61
Income | -8.8M -45M |
|---|---|
Sales | -11M 11M |
EPS | -1.78 |
Profit margin | -413.443 |
Employees | 63 |
EBITDA | -18M -37M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +120.86% upside |
Next Earnings | 13 Aug 2026 |
|---|
Market Cap | -403M 2.5B |
|---|---|
Previous open | 75.12 |
Previous close | 76 |
Nektar Therapeutics Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
120.86% upside
12 Months Forecast
Average 166.75 USD 120.86%
High 185 USD
Low 151 USD
Based on 4 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$